Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health

J Am Acad Dermatol. 2017 Jan;76(1):1-9. doi: 10.1016/j.jaad.2016.01.062.

Abstract

Systemic glucocorticoids are an essential therapy for a range of conditions, but their multiple side effects can produce significant morbidity for patients. The objective of this review is to discuss these side effects while addressing 3 questions: 1) What dose and duration of glucocorticoid therapy should prompt concern for individual side effects?; 2) How should clinicians counsel patients about these complications?; and 3) How can these problems be prevented or managed? To accomplish these objectives, we have created a series of tables and algorithms based on a review of relevant data to guide counseling, prophylaxis, and management of 11 glucocorticoid side effects. The first article in this 4-part continuing medical education series begins with a review of glucocorticoid pharmacology followed by a discussion of bone health (ie, osteoporosis and osteonecrosis).

Keywords: glucocorticoids; medication monitoring; osteonecrosis; osteoporosis; pharmacology; side effects; steroids.

Publication types

  • Review

MeSH terms

  • Bone Density Conservation Agents / therapeutic use
  • Glucocorticoids / adverse effects*
  • Glucocorticoids / pharmacology*
  • Humans
  • Osteonecrosis / chemically induced*
  • Osteonecrosis / drug therapy*
  • Osteonecrosis / prevention & control
  • Osteoporosis / chemically induced*
  • Osteoporosis / drug therapy*
  • Osteoporosis / prevention & control

Substances

  • Bone Density Conservation Agents
  • Glucocorticoids